Among the devils in the details are protease sequence, susceptibility, and structure in CRF02_AG viruses.
David
D
Katzenstein
Richard
R
Ogden
D024921:Drug Resistance, Multiple, Viral; D015658:HIV Infections / Q000188:drug therapy*; D016333:HIV Protease / Q000737:chemistry / Q000378:metabolism*; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D006801:Humans
D017320:HIV Protease Inhibitors; D016333:HIV Protease